Farzad Nazem Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 77

  • Portfolio
  • 22

  • Exits
  • 49

Exits

Farzad Nazem General Information

Description

Mr. Farzad Nazem serves as an Advisor at SignalFire and Arrcus. He serves as a Board Member at Nautilus Biotechnology. He also serves as a Strategic Advisor at January AI. He earned a B.S. degree in Computer Science with highest honors. He serves on the boards of NextBio and HAND Foundation. He is the former Chief Technology Officer of Yahoo! Inc. At Yahoo, he also served as Executive Vice President of Engineering & Site Operations, Senior Vice President of Communications & Technical Services, and Senior Vice President of Product Development & Site Operations. Before Yahoo, Zod held several technical and executive management positions at Oracle Corporation, including Vice President of Oracle's Media and Web Server Division. He earned a B.S. degree in Computer Science with highest honors from California Polytechnic State University.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • Silicon Valley
  • San Francisco, CA
  • United States
+1 (650) 000-0000

Farzad Nazem Investments (77)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Arrcus 10-Jul-2023 Later Stage VC 0000 Business/Productivity Software Generating Revenue 000000 00000
GEn1E Lifesciences 21-Dec-2022 00000 00000 0000 Drug Discovery Generating Revenue 000000 00000
January 15-Aug-2022 00000 00000 0000 Other Healthcare Services Generating Revenue 000000 00000
Trackonomy 14-Oct-2021 00000 00000 00000 Business/Productivity Software Generating Revenue 000000 00000
Zenda 29-Oct-2020 0000 00000 000 Financial Software Generating Revenue 000000 00000
Atomwise 02-Jul-2018 00000 00000 000.00 Drug Discovery Generating Revenue 000000 00000
Ceevra 30-Jun-2018 0000 00000 00000 Decision/Risk Analysis Generating Revenue 000000 00000
Persephone Biosciences 20-Mar-2018 0000 00000 00.00 Drug Discovery Generating Revenue 000000 00000
TigerGraph 18-Sep-2017 Later Stage VC 0000 Database Software Generating Revenue 000000 00000
BioAge 28-Jul-2017 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2 000000 00000

Farzad Nazem Exits (49)

Company Name Exit Date Exit Type Exit Size
Amitree 15-Feb-2024 Buyout/LBO
Imprint Energy 29-Aug-2023 000000000000000000 000.00
Zenda 07-Aug-2023 000000000000000000
Prodea 01-Jun-2023 000 00 00000000
Hāpara 24-Jan-2023 0000000000
Arterys 03-Oct-2022 000000000000000000
Rigetti Computing 02-Mar-2022 0000000 000000 000
Ginkgo Bioworks 17-Sep-2021 0000000 000000 00.000
Edge Intelligence (Business/Productivity Software) 16-Aug-2021 Merger/Acquisition
Enso Relief 09-Mar-2021 Merger/Acquisition

Farzad Nazem Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Farzad Nazem Team (1)

Name Title Deals Funds Boards Office
Farzad Nazem Angel Investor 00 0 San Francisco, CA

Farzad Nazem Co-Investors (52)

Name With Exits Lead Partner Series Industry
Clear Ventures 2 0 Series chart Industry bar
EDBI 0 0 Series chart Industry bar
General Catalyst 0 0 Series chart Industry bar
SVB Financial Group 0 0 Series chart Industry bar
Sierra Ventures 0 0 0 Series chart Industry bar

Farzad Nazem FAQs

  • Who is Farzad Nazem?

    Farzad Nazem is an angel Investor who has made 77 investments.

  • What kind of investor is Farzad Nazem?

    Farzad Nazem is an angel investor.

  • What does Farzad Nazem do?

    As an angel investor, Farzad Nazem invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Farzad Nazem hold?

    Farzad Nazem holds a board seat in Nautilus Biotechnology.

  • What has Farzad Nazem invested in?

    Farzad Nazem has made numerous investments in companies like Arrcus, GEn1E Lifesciences, and January within the Business/Productivity Software, Drug Discovery, and Healthcare Services industries.

  • What has Farzad Nazem invested in recently?

    Farzad Nazem's latest investment was on 10-Jul-2023 in Arrcus, a company within the Business/Productivity Software industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »